JMGZX
Price
$49.22
Change
-$0.26 (-0.53%)
Updated
Nov 12 closing price
RPTIX
Price
$113.32
Change
-$0.78 (-0.68%)
Updated
Nov 12 closing price
Ad is loading...

JMGZX vs RPTIX

Header iconJMGZX vs RPTIX Comparison
Open Charts JMGZX vs RPTIXBanner chart's image
JPMorgan Mid Cap Growth R2
Price$49.22
Change-$0.26 (-0.53%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$113.32
Change-$0.78 (-0.68%)
VolumeN/A
CapitalizationN/A
JMGZX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMGZX vs. RPTIX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMGZX is a StrongBuy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32.3B vs. JMGZX (12.1B). RPTIX pays higher dividends than JMGZX: RPTIX (0.18) vs JMGZX (0.00). JMGZX was incepted earlier than RPTIX: JMGZX (15 years) vs RPTIX (9 years). JMGZX is a more actively managed with annual turnover of: 45.00 vs. RPTIX (21.70). JMGZX has a lower initial minimum investment than RPTIX: JMGZX (0) vs RPTIX (500000). JMGZX annual gain was more profitable for investors over the last year : 34.08 vs. RPTIX (21.29). JMGZX return over 5 years is better than : 33.39 vs. RPTIX (18.66).
JMGZXRPTIXJMGZX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years9 years-
Gain YTD18.51713.037142%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B32.3B37%
Annual Yield % from dividends0.000.18-
Returns for 1 year34.0821.29160%
Returns for 3 years-10.40-14.6471%
Returns for 5 years33.3918.66179%
Returns for 10 years64.89N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions